1. |
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med, 2007, 176(8): 753-760.
|
2. |
Liu SM, Zhou YM, Wang XP, et al. Biomass fuels are the probable risk factor of chronic obstructive pulmonary disease in rural south china. Thorax, 2007, 62: 889-897.
|
3. |
周玉民, 王辰, 姚婉贞, 等. 职业接触粉尘和烟雾对慢性阻塞性肺疾病及呼吸道症状的影响. 中国呼吸与危重监护杂志, 2009, 8(1): 6-11.
|
4. |
Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med, 2011, 183(4): 455-461.
|
5. |
Liu S, Zhou Y, Liu S, et al. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax, 2017, 72(9): 788-795.
|
6. |
Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet, 2005, 365: 2225-2236.
|
7. |
Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med, 2009, 361(27): 2599-2608.
|
8. |
胡国平, 彭公永, 胡锦兴, 等. 肿瘤坏死因子 α-308 基因多态性与慢性阻塞性肺疾病易感性的荟萃分析. 中华结核和呼吸杂志, 2007, 30(8): 588-594.
|
9. |
Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet, 2009, 5(3): e1000421.
|
10. |
Qiao D, Lange C, Beaty TH, et al. Exome sequencing analysis in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2016, 193(12): 1353-1363.
|
11. |
Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J, 2013, 42(3): 636-646.
|
12. |
Duvoix A, Dickens J, Haq I, et al. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax, 2013, 68(7): 670-676.
|
13. |
Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J, 2014, 44(6): 1697-1700.
|
14. |
钟南山. 早发现、早诊断和早干预应是我国慢性阻塞性肺疾病防治的主要研究方向. 中华结核和呼吸杂志, 2012, 35(4): 243-245.
|
15. |
Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med, 2011, 365(13): 1184-1192.
|
16. |
Zhou Y, Zhong N, Li XC, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med, 2017, 377(10): 923-935.
|
17. |
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med, 2017, 195(5): 557-582.
|
18. |
Miravitiles M, Soler-Cataluna JJ, Cahell M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J, 2013, 41(6): 1252-1256..
|
19. |
张弘, 蔡柏蔷. 慢性阻塞性肺疾病急性加重临床研究进展. 中国呼吸与危重监护杂志, 2016, 15(2): 198-202.
|
20. |
Brightling CE. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease. Ann Am Thorac Soc, 2013, 10(Suppl): S214-S219.
|
21. |
Wedzicha JA Ers Co-Chair, Miravitlles M, Hurst JR, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J, 2017, 49(3): pii: 1600791.
|